These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39412702)

  • 21. PET imaging with [
    Tang J; Xu Y; Liu C; Fang Y; Cao S; Zhao C; Huang H; Zou M; Chen Z
    Nucl Med Biol; 2020; 90-91():1-9. PubMed ID: 32861175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT.
    Jiang D; Kong Y; Ren S; Cai H; Zhang Z; Huang Z; Peng F; Hua F; Guan Y; Xie F
    Nucl Med Biol; 2020; 82-83():89-95. PubMed ID: 32120243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of Vesicular Monoamine Transporter 2 in Myopic Retina Using [
    Sun Y; Zhao N; Liu W; Liu M; Ju Z; Li J; Cheng Z; Liu X
    Mol Imaging Biol; 2018 Oct; 20(5):771-779. PubMed ID: 29520623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative study of
    Jung Lung H; Weng YH; Wen MC; Hsiao IT; Lin KJ
    Sci Rep; 2018 Oct; 8(1):16027. PubMed ID: 30375444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
    Kilbourn MR; Hockley B; Lee L; Hou C; Goswami R; Ponde DE; Kung MP; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):233-7. PubMed ID: 17383572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [¹⁸F]FP-DTBZ in baboons.
    Harris PE; Farwell MD; Ichise M
    Nucl Med Biol; 2013 Jan; 40(1):60-4. PubMed ID: 23102539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP
    PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging of VMAT2 binding sites in the brain by (18)F-AV-133: the effect of a pseudo-carrier.
    Zhu L; Qiao H; Lieberman BP; Wu J; Liu Y; Pan Z; Ploessl K; Choi SR; Chan P; Kung HF
    Nucl Med Biol; 2012 Oct; 39(7):897-904. PubMed ID: 22749185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
    Boileau I; Rusjan P; Houle S; Wilkins D; Tong J; Selby P; Guttman M; Saint-Cyr JA; Wilson AA; Kish SJ
    J Neurosci; 2008 Sep; 28(39):9850-6. PubMed ID: 18815269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas.
    Fagerholm V; Mikkola KK; Ishizu T; Arponen E; Kauhanen S; Någren K; Solin O; Nuutila P; Haaparanta M
    J Nucl Med; 2010 Sep; 51(9):1439-46. PubMed ID: 20720057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy.
    Ma JH; Dong C; Qiao HW; Barret O; Tamagnan GD; Mao W; Xu EH; Zhang C; Lu J; Chan P; Liu SY
    Mov Disord; 2024 May; 39(5):847-854. PubMed ID: 38477228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent.
    Jiang D; Lu X; Li Z; Rydberg N; Zuo C; Peng F; Hua F; Guan Y; Xie F
    Front Neurosci; 2018; 12():1052. PubMed ID: 30697146
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
    Kung HF; Lieberman BP; Zhuang ZP; Oya S; Kung MP; Choi SR; Poessl K; Blankemeyer E; Hou C; Skovronsky D; Kilbourn M
    Nucl Med Biol; 2008 Nov; 35(8):825-37. PubMed ID: 19026944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements.
    Lin KJ; Lin WY; Hsieh CJ; Weng YH; Wey SP; Lu CS; Skovronsky D; Yen TC; Chang CJ; Kung MP; Hsiao IT
    Nucl Med Biol; 2011 Nov; 38(8):1149-55. PubMed ID: 21831650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Purification Method of
    Dai Y; Sa R; Guan F; Wang Q; Li Y; Zhao H
    Front Med (Lausanne); 2021; 8():693632. PubMed ID: 34307421
    [No Abstract]   [Full Text] [Related]  

  • 36. Elucidating the Relationship Between Diabetes Mellitus and Parkinson's Disease Using
    Kong Y; Zhou H; Feng H; Zhuang J; Wen T; Zhang C; Sun B; Wang J; Guan Y
    Front Neurosci; 2020; 14():682. PubMed ID: 32760240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
    Frey KA; Koeppe RA; Kilbourn MR; Vander Borght TM; Albin RL; Gilman S; Kuhl DE
    Ann Neurol; 1996 Dec; 40(6):873-84. PubMed ID: 9007092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
    Huang ZR; Tsai CL; Huang YY; Shiue CY; Tzen KY; Yen RF; Hsin LW
    PLoS One; 2016; 11(9):e0161295. PubMed ID: 27612194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2.
    Zhu L; Liu Y; Plössl K; Lieberman B; Liu J; Kung HF
    Nucl Med Biol; 2010 Feb; 37(2):133-41. PubMed ID: 20152712
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.